XBiotech Announces Receipt of $75 Million from Sale of Antibody

NEXT STORY
Freeline Announces Executive Leadership Changes
PREV STORY
Therapeutic Respiratory Devices Market will reach US$45,611.2 Million in 2031: Visiongain Research Inc.
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cytokinetics Completes Enrollment in VITALITY-ALS, Phase 3 Clinical Trial of Tirasemtiv in Patients With ALS

SOUTH SAN FRANCISCO, Calif., Aug. 17, 2016 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq:CYTK) today ...

author_avatar
NASDAQ Market News

Roche receives FDA clearance for BK virus quantitative test on cobas 6800/8800 Systems to support better care for transplant patients

author_avatar
NASDAQ Market News

Zentalis Pharmaceuticals Enters into Clinical Collaboration and Supply Agreement with GlaxoSmithKline to Evaluate its Oral WEE1 Inhibitor, ZN-c3, in Combination with Niraparib, a PARP Inhibitor

author_avatar
NASDAQ Market News